Khaled A. Chehab
Johnson & Johnson
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Khaled A. Chehab.
Optometry and Vision Science | 2016
Xu Cheng; Jing Xu; Khaled A. Chehab; Joan M. Exford; Noel A. Brennan
Purpose To determine whether soft contact lenses with positive spherical aberration (+SA) can slow myopia progression. Methods Eligible subjects (N = 127, primarily Asian) aged 8 to 11 years were randomized to wear either control (spherical design) or test (with +SA) soft daily disposable contact lenses for a minimum of 1 and up to 2 years (treatment phase). Subjects from the initial cohorts (N = 82) were then followed for an additional 1.5 years while wearing a marketed spherical daily disposable contact lens (withdrawal phase). Axial length and spherical equivalent cycloplegic autorefraction (SECAR) were measured at baseline and every 6 months in both phases. Results During the first year of treatment, lens type (test vs. control) had a statistically significant impact on axial elongation (p = 0.0409). Eyes wearing test lenses increased in length by 0.11 (65.3%) and 0.14 (38.6%) mm less than eyes wearing control soft lenses at 6 and 12 months, respectively (p < 0.05 at both time points). The principal control of axial elongation occurred during the first 6 months. Spherical equivalent cycloplegic autorefraction change from baseline was significantly less in the test cohort than the control cohort by 0.21D (54.0%) at 6 months (p < 0.05) but not at 12 months (0.14D, p > 0.05). Lens type was not overall a significant factor affecting refractive error change (p = 0.0677). After ceasing treatment, neither the rate of axial elongation nor change in SECAR was significantly different between the initial two cohorts. Conclusions The soft contact lens with +SA slowed axial growth of the eye, although this did not translate into a sustained statistically significant effect on SECAR. The majority of the treatment effect occurred in the initial 6 months of wear. No evidence of rebound effect was observed after ceasing treatment.
Archive | 1999
Jongliang Wu; Khaled A. Chehab; Carl Crowe; Timothy R. Poling; Richard J. Nason; Jon Scott Walker; Susan-Wendy B. Neadle; Patricia Anne Hutfles; W. Anthony Martin
Archive | 1999
Jongliang Wu; Khaled A. Chehab; Carl Crowe; Victor Lust; Richard J. Nason; Timothy R. Poling; Jon Scott Walker
Archive | 2006
Khaled A. Chehab; Michael J. Collins; Jeffrey H. Roffman; Ross Franklin; Brett A. Davis; Xu Cheng
Archive | 2009
Timothy A. Clutterbuck; Khaled A. Chehab; Edgar V. Menezes; Steven Ernest Franklin; Cornelis Petrus Hendriks; William Potze
Archive | 2010
Michael J. Collins; Brett A. Davis; Khaled A. Chehab; Xu Cheng; D. Robert Iskander
Archive | 2011
Jeffrey H. Roffman; Philippe F. Jubin; Edgar V. Menezes; Pierre-Yves Gerligand; Timothy A. Clutterbuck; Khaled A. Chehab
Archive | 2002
Frank F. Molock; Khaled A. Chehab; James D. Ford; Ture Kindt-Larsen; Craig William Walker; Joe M. Wood; Julieann E. Weber; Gary L. Collins
Archive | 2014
Xin Wei; Noel A. Brennan; Khaled A. Chehab; Jeffrey H. Roffman; C. Benjamin Wooley
Archive | 2014
Khaled A. Chehab; Arthur Shedden; Xu Cheng